🇺🇸 FDA
Pipeline program

LIBTAYO 350 mg concentrate for solution for infusion., Vinorelbine 10 mg/ml concentrate for solution for infusion, TAXOTERE 20 mg/0.5 ml concentrate and solvent for solution for infusion, THIO, Gemcitabine 1 g Powder for Solution for Infusion

THIO-104

Phase 3 small_molecule active

Quick answer

LIBTAYO 350 mg concentrate for solution for infusion., Vinorelbine 10 mg/ml concentrate for solution for infusion, TAXOTERE 20 mg/0.5 ml concentrate and solvent for solution for infusion, THIO, Gemcitabine 1 g Powder for Solution for Infusion for Non-Small Cell Lung Cancer is a Phase 3 program (small_molecule) at MAIA Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
MAIA Biotechnology
Indication
Non-Small Cell Lung Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials